The company's SIS hydrogel is used to accelerate chronic wound healing research article "Mechanically active small intestinal submucosa hydrogel for accelerating chronic wound healing" was included in the authoritative journal "Journal of Materials Chemistry B" in the field of biomedical materials, with an impact factor of 7.571.
We showed our heavy core products to visitors Hernia Graft, Oral Matrix, Wound Matrix, Dural Repair Patch, Pericardial Patch, Protective Film , Vascular Repair Matrix and other products.
From July 21st to July 23rd, 2022, the three-day "Biosis Healing the second half of 2022 strategy launch meeting and sales annual meeting" was successfully held.
Guided bone regeneration (GBR)
In this paper, VIDASIS from Biosis Healing and Biodesign from COOK, United States, are selected to be quantitatively detected and studied on the content of FN. The article was published in the “Journal of Biology” in Feb. 2018.
July 7, 2022, on the day of Minor Heat, Biosis Healing held an exciting and enthusiastic founding congress of Neurosurgery Sales Division officially, aiming at Neurosurgery sub-field track with huge potential.
This paper focuses on the quantitative detection of three growth factors (TGF-β, VEGF and FGF) in SIS materials, and the detection results are obtained by two experimental methods. The article was published in the journal Materials Science in May 2018. The following are excerpts.
In this paper, the physical properties of porcine small intestinal submucosa matrix material (SIS) and commercially available acellular bovine dermal matrix (ADM) were compared and investigated, including morphology, roughness, hydrophilicity and softness.
In order to encourage young talents in the field of stomatology to actively carry out research work, the Chinese Stomatological Association has set up a series of youth scientific research fund projects, built a scientific research platform of multiple disciplines, and helped the growth of dental talents.
On April 6th, one of the "key members" of the SIS series products of Biosis Healing - 博瑞金 Oral Biological Graft, was approved by NMPA for the registration of Class III medical devices [国械注准 20223170457].